Rep. Mariannette Miller-Meeks

Maddy summaryThe SIREN Reauthorization Act (HR 4646) reauthorizes a federal program supporting rural emergency medical services (EMS) from 2024 through 2028. It directly affects rural EMS providers and personnel by requiring training on mental health and substance use disorders in emergency settings and allowing the acquisition of FDA-approved drugs for overdose treatment. Key provisions include updating the program's funding period, mandating new training standards for EMS staff, and expanding equipment access to include overdose-reversal medications. The bill amends Section 330J of the Public Health Service Act to implement these changes.

Maddy summaryHJRES 145 is a joint resolution seeking congressional disapproval of a specific FDA rule regarding medical tests developed in laboratories (LDTs). It targets the FDA's May 2024 rule (89 Fed. Reg. 37286) that would have regulated these tests as medical devices. The resolution uses the Congressional Review Act (Chapter 8 of Title 5, U.S. Code) to block the rule from taking effect, stating it "shall have no force or effect." This resolution directly affects the FDA's regulatory authority over laboratory-developed medical tests but does not change existing medical device laws.

Maddy summaryThe SCREENS for Cancer Act of 2024 reauthorizes and expands the National Breast and Cervical Cancer Early Detection Program (NBCCEDP), which provides free screenings and care coordination to low-income, uninsured, or underinsured women. It increases annual funding from $275 million (2024) to $500 million (2028) and explicitly adds "prevention" to the program’s mission, requiring it to reduce racial and ethnic disparities in cancer outcomes. The bill mandates the program to address barriers like social determinants of health and implement evidence-based strategies to boost screenings, particularly for underserved communities disproportionately affected by pandemic-related screening declines. This directly benefits millions of women, especially Black, Hispanic, and Asian women, who face higher cancer death rates and reduced access to care.

Maddy summaryThis bill requires the U.S. Department of Defense and State Department to immediately deliver all previously approved military equipment and services to Israel within 15 days, reversing any pauses on arms transfers. It prohibits using federal funds to withhold, halt, or cancel defense article deliveries to Israel and mandates that unobligated security assistance funds for Israel must be spent by the end of 30 days. The bill also requires monthly reports to Congress detailing all security assistance provided to Israel since October 7, 2023, including specific items delivered and funding sources. The law directly affects U.S. agencies responsible for military aid and Israel as the recipient of the security assistance.

Maddy summaryHJRES 138 is a joint resolution seeking congressional disapproval of a Centers for Medicare & Medicaid Services (CMS) rule that would have clarified eligibility for health insurance subsidies under the Affordable Care Act for Deferred Action for Childhood Arrivals (DACA) recipients and certain noncitizens. The rule, submitted on May 8, 2024, aimed to allow these individuals to access premium tax credits, cost-sharing reductions, and health plans through ACA marketplaces. This resolution, if enacted, would block the rule from taking effect under the Congressional Review Act, directly preventing DACA recipients and the specified noncitizens from qualifying for these benefits. The bill does not create new policy but halts an existing regulatory clarification.

Maddy summaryHR 8415, the Strengthening Cybersecurity in Health Care Act, requires the Department of Health and Human Services (HHS) Inspector General to conduct regular cybersecurity evaluations every two years. These evaluations use security testing to assess how systems handling sensitive health data - like Medicare numbers and patient safety systems - could be compromised. The bill mandates that HHS submit reports to Congress on updating cybersecurity practices and the Inspector General must report on funding use and needed legislative changes for ongoing evaluations. This directly affects HHS operations and the security of patient data across the healthcare system. The law aims to proactively identify and address vulnerabilities in critical health information systems.

Maddy summaryThe MIRACLE Medical Technology Act of 2024 establishes a formal U.S.-Israel collaboration program to advance joint development and delivery of healthcare products and services. It creates a U.S.-Israel Health Care Collaboration Center to facilitate research (including medical devices, pharmaceuticals, and digital health), regulatory alignment, manufacturing partnerships, and disease prevention efforts. The program requires annual funding of $8 million (2025-2029) and focuses on concrete mechanisms like shared clinical trials, data-sharing frameworks, and joint manufacturing facilities. It directly affects U.S. and Israeli healthcare institutions, medical technology companies, and research organizations working on healthcare innovation.

Maddy summaryHR 7581 requires the Attorney General to submit three new reports within 270 days of enactment, focusing on data gaps affecting law enforcement safety. The bill mandates a detailed analysis of violent attacks against officers (including ambushes), non-criminal aggressive incidents not currently reported, and mental health impacts from such events. These reports will assess current data collection systems, training effectiveness, resource availability, and disparities in reporting across federal, state, and local law enforcement. The goal is to inform better prevention strategies and resource allocation for officer safety and wellness, without creating new funding or programs.

Maddy summaryThis bill requires Medicare to pay separately for certain high-cost diagnostic drugs used in nuclear imaging (like those for cancer detection) starting in 2024. It applies to drugs with a daily cost of $500 or more (adjusted annually), ensuring they are not bundled with other services. Payments will be based on either the drug's average sales price or wholesale cost, with adjustments to keep overall Medicare spending unchanged. This directly affects Medicare Part B providers (hospitals, clinics) and beneficiaries receiving these specific diagnostic treatments.

Maddy summaryHR 8335, the "Billion Dollar Boondoggle Act of 2024," requires federal agencies to publicly report on major projects that are either significantly delayed or exceed their original budget by over $1 billion. Specifically, it mandates that agencies like the Department of Defense or Environmental Protection Agency submit annual reports detailing the status of such projects - including original vs. current costs, completion timelines, and reasons for delays or cost overruns. The reports must include project locations, key contractors, and explanations for budget increases, such as funding shortfalls. This bill does not alter spending or stop projects but aims to improve transparency around large-scale federal expenditures. It applies only to projects meeting the defined thresholds, not all government spending.